G6PD and neoplasm: MicroRNA has also been reported to inhibit tumor growth by targeting G6PD. In renal cell carcinoma, large-scale transcriptome and metabolic analyses showed that miR-146a-5p and miR-155-5p were involved in PPP reprogramming (Boguslawska et al., 2019).